Mary C. Beckerle - Feb 15, 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
Director
Signature
Raavi K. Deol, as attorney-in-fact for Mary C. Beckerle
Stock symbol
JNJ
Transactions as of
Feb 15, 2022
Transactions value $
$0
Form type
4
Date filed
2/17/2022, 03:46 PM
Next filing
Feb 22, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Deferred Share Units Award $0 +1.18K +12.8% $0.00 10.4K Feb 15, 2022 Common Stock 1.18K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).